These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 15699188)

  • 41. Instantaneous within-patient diversity of Pseudomonas aeruginosa quorum-sensing populations from cystic fibrosis lung infections.
    Wilder CN; Allada G; Schuster M
    Infect Immun; 2009 Dec; 77(12):5631-9. PubMed ID: 19805523
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation.
    Price KE; Orazi G; Ruoff KL; Hebert WP; O'Toole GA; Mastoridis P
    PLoS One; 2015; 10(10):e0141192. PubMed ID: 26506004
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibacterial and antibiofilm effect of Zinc Oxide nanoparticles on P. aeruginosa variants isolated from young patients with cystic fibrosis.
    Konkuri M; Kharrazi S; Erfani Y; Haghighat S
    Microb Pathog; 2024 Oct; 195():106854. PubMed ID: 39151738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Scaffold of Selenium Nanovectors and Honey Phytochemicals for Inhibition of
    Prateeksha ; Singh BR; Shoeb M; Sharma S; Naqvi AH; Gupta VK; Singh BN
    Front Cell Infect Microbiol; 2017; 7():93. PubMed ID: 28386534
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
    Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746
    [No Abstract]   [Full Text] [Related]  

  • 46. Pleiotropic effects of acyltransferases on various virulence-related phenotypes of Pseudomonas aeruginosa.
    Yeom DH; Kim SK; Lee MN; Lee JH
    Genes Cells; 2013 Aug; 18(8):682-93. PubMed ID: 23848169
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of quorum-sensing-dependent virulence factors and biofilm formation of clinical and environmental Pseudomonas aeruginosa strains by ZnO nanoparticles.
    García-Lara B; Saucedo-Mora MÁ; Roldán-Sánchez JA; Pérez-Eretza B; Ramasamy M; Lee J; Coria-Jimenez R; Tapia M; Varela-Guerrero V; García-Contreras R
    Lett Appl Microbiol; 2015 Sep; 61(3):299-305. PubMed ID: 26084709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. P. aeruginosa Biofilms in CF Infection.
    Wagner VE; Iglewski BH
    Clin Rev Allergy Immunol; 2008 Dec; 35(3):124-34. PubMed ID: 18509765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exemplifying the next generation of antibiotic susceptibility intensifiers of phytochemicals by LasR-mediated quorum sensing inhibition.
    Shukla A; Shukla G; Parmar P; Patel B; Goswami D; Saraf M
    Sci Rep; 2021 Nov; 11(1):22421. PubMed ID: 34789810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa.
    Skindersoe ME; Alhede M; Phipps R; Yang L; Jensen PO; Rasmussen TB; Bjarnsholt T; Tolker-Nielsen T; Høiby N; Givskov M
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3648-63. PubMed ID: 18644954
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interference of Pseudomonas aeruginosa signalling and biofilm formation for infection control.
    Bjarnsholt T; Tolker-Nielsen T; Høiby N; Givskov M
    Expert Rev Mol Med; 2010 Apr; 12():e11. PubMed ID: 20370936
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro evolution of Pseudomonas aeruginosa AA2 biofilms in the presence of cystic fibrosis lung microbiome members.
    Vandeplassche E; Sass A; Lemarcq A; Dandekar AA; Coenye T; Crabbé A
    Sci Rep; 2019 Sep; 9(1):12859. PubMed ID: 31492943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence for Complex Interplay between Quorum Sensing and Antibiotic Resistance in Pseudomonas aeruginosa.
    Sikdar R; Elias MH
    Microbiol Spectr; 2022 Dec; 10(6):e0126922. PubMed ID: 36314960
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epigallocatechin Gallate Remodels Overexpressed Functional Amyloids in Pseudomonas aeruginosa and Increases Biofilm Susceptibility to Antibiotic Treatment.
    Stenvang M; Dueholm MS; Vad BS; Seviour T; Zeng G; Geifman-Shochat S; Søndergaard MT; Christiansen G; Meyer RL; Kjelleberg S; Nielsen PH; Otzen DE
    J Biol Chem; 2016 Dec; 291(51):26540-26553. PubMed ID: 27784787
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
    Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA
    J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model.
    Christensen LD; van Gennip M; Jakobsen TH; Alhede M; Hougen HP; Høiby N; Bjarnsholt T; Givskov M
    J Antimicrob Chemother; 2012 May; 67(5):1198-206. PubMed ID: 22302561
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyperbaric oxygen treatment increases killing of aggregating Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Møller SA; Jensen PØ; Høiby N; Ciofu O; Kragh KN; Bjarnsholt T; Kolpen M
    J Cyst Fibros; 2019 Sep; 18(5):657-664. PubMed ID: 30711384
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The salicylidene acylhydrazide INP0341 attenuates Pseudomonas aeruginosa virulence in vitro and in vivo.
    Uusitalo P; Hägglund U; Rhöös E; Scherman Norberg H; Elofsson M; Sundin C
    J Antibiot (Tokyo); 2017 Aug; 70(9):937-943. PubMed ID: 28588224
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Affecting Pseudomonas aeruginosa phenotypic plasticity by quorum sensing dysregulation hampers pathogenicity in murine chronic lung infection.
    Bondí R; Messina M; De Fino I; Bragonzi A; Rampioni G; Leoni L
    PLoS One; 2014; 9(11):e112105. PubMed ID: 25420086
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specific resistance to Pseudomonas aeruginosa infection in zebrafish is mediated by the cystic fibrosis transmembrane conductance regulator.
    Phennicie RT; Sullivan MJ; Singer JT; Yoder JA; Kim CH
    Infect Immun; 2010 Nov; 78(11):4542-50. PubMed ID: 20732993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.